All Stories

  1. Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial

    Article • American Journal of Transplantation, October 2017, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN, Dr Francesc Moreso

  2. Intermediate steroid withdrawal after renal transplantation and anti-HLA antibodies (HLA-Abs) development

    Article • Nefrología, July 2017, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  3. Intermediate steroid withdrawal after renal transplantation and anti-HLA antibodies (HLA-Abs) development

    Article • Nefrología (English Edition), July 2017, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  4. Improving the Outcomes of Organs Obtained From Controlled Donation After Circulatory Death Donors Using Abdominal Normothermic Regional Perfusion

    Article • American Journal of Transplantation, March 2017, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  5. ADHERE: randomized controlled trial comparing renal function inde novokidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus

    Article • Transplant International, November 2016, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  6. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?

    Article • Transplantation Proceedings, November 2016, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  7. Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results

    Article • Transplantation Proceedings, November 2016, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  8. Relationship Between Albuminuria During the First Year and Antibody-Mediated Rejection in Protocol Biopsies in Kidney Transplant Recipients

    Article • Transplantation Proceedings, November 2016, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  9. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development

    Article • Transplantation, November 2016, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  10. A high sodium intake reduces antiproteinuric response to renin–angiotensin–aldosterone system blockade in kidney transplant recipients

    Article • Nefrología (English Edition), September 2016, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  11. La ingesta elevada de sodio disminuye la respuesta antiproteinúrica del bloqueo del eje renina-angiotensina-aldosterona en el trasplante renal

    Article • Nefrología, September 2016, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  12. Clinical evolution of post-transplant diabetes mellitus

    Article • Nephrology Dialysis Transplantation, November 2015, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  13. Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted From Twice-Daily to Once-Daily Tacrolimus

    Article • Transplantation Direct, August 2015, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  14. Frequencies of Circulating B-Cell Subpopulations Before Kidney Transplantation Identify Patients at Risk of Acute Rejection

    Article • Transplantation Proceedings, January 2015, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  15. Number of Antihypertensive Drugs at 1 Year After Kidney Transplantation

    Article • Transplantation Proceedings, January 2015, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  16. Sodium Excretion Pattern at 1 Year After Kidney Transplantation and High Blood Pressure

    Article • Annals of Transplantation, January 2015, International Scientific Literature

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  17. Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors

    Article • Transplant International, June 2014, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  18. Cystatin C and albuminuria as predictors of long-term allograft outcomes in kidney transplant recipients

    Article • Clinical Transplantation, February 2013, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  19. Anemia Control in Renal Transplant Recipients Receiving Continuous Erythropoietin Receptor Activator (C.E.R.A.) Treatment: The AnemiaTrans Study

    Article • Advances in Therapy, November 2012, Springer Science + Business Media

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  20. High Regulatory T-Cell Levels at 1 Year Posttransplantation Predict Long-Term Graft Survival Among Kidney Transplant Recipients

    Article • Transplantation Proceedings, November 2012, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  21. New-onset Diabetes After Transplantation: Drug-Related Risk Factors

    Article • Transplantation Proceedings, November 2012, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  22. Prediction of Kidney Transplant Outcome by Donor Quality Scoring Systems: Expanded Criteria Donor and Deceased Donor Score

    Article • Transplantation Proceedings, November 2012, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  23. Relation of Urinary Gene Expression of Epithelial-Mesenchymal Transition Markers With Initial Events and 1-Year Kidney Graft Function

    Article • Transplantation Proceedings, November 2012, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  24. Aggressive lung donor management increases graft procurement without increasing renal graft loss after transplantation

    Article • Clinical Transplantation, August 2012, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  25. Giant Cavernous Hemangioma in Renal Graft: A Case Report

    Article • Transplantation Proceedings, June 2012, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  26. Everolimus as Primary Immunosuppression in Kidney Transplantation

    Article • Transplantation, February 2012, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  27. Management of proteinuria in clinical practice after kidney transplantation

    Article • Transplantation Reviews, January 2012, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  28. Prediction of Delayed Graft Function by Means of a Novel Web-Based Calculator: A Single-Center Experience

    Article • American Journal of Transplantation, October 2011, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  29. Changes in the number of circulating TCM and TEM subsets in renal transplantation: relationship with acute rejection and induction therapy

    Article • Kidney International Supplements, August 2011, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  30. Early Prediction of New-Onset Diabetes Mellitus by Fifth-Day Fasting Plasma Glucose, Pulse Pressure, and Proteinuria

    Article • Transplantation Proceedings, July 2011, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  31. Is Proteinuria Reversible, After Withdrawal of Mammalian Target of Rapamycin Inhibitors?

    Article • Transplantation Proceedings, July 2011, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  32. Efficacy and Safety of Conversion from Twice-daily to Once-daily Tacrolimus in a Large Cohort of Stable Kidney Transplant Recipients

    Article • American Journal of Transplantation, June 2011, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  33. Protocolo diagnóstico de la oligoanuria

    Article • Medicine - Programa de Formación Médica Continuada Acreditado, June 2011, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  34. Mean Glomerular Volume After Renal Transplantation in Patients Receiving Sirolimus and Cyclosporine A Compared With Elimination of Cyclosporine A at 3 Months

    Article • Transplantation, January 2011, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  35. Analysis of Urinary Gene Expression of Epithelial-Mesenchymal Transition Markers in Kidney Transplant Recipients

    Article • Transplantation Proceedings, October 2010, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  36. Anemia Control in Kidney Transplant Patients Treated With Methoxy Polyethylene Glycol-Epoetin Beta (Mircera): The Anemiatrans Group

    Article • Transplantation Proceedings, October 2010, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  37. Comparative Analysis of Adverse Events Requiring Suspension of mTOR Inhibitors: Everolimus versus Sirolimus

    Article • Transplantation Proceedings, October 2010, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  38. Influence of Interleukin-6 Promoter Polymorphism −174 G/C on Kidney Graft Outcome

    Article • Transplantation Proceedings, October 2010, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  39. Kidney Transplant Recipients Show an Increase in the Ratio of T-Cell Effector Memory/Central Memory as Compared to Nontransplant Recipients on the Waiting List

    Article • Transplantation Proceedings, October 2010, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  40. Number of Peripheral Blood Regulatory T Cells and Lymphocyte Activation at 3 Months After Conversion to mTOR Inhibitor Therapy

    Article • Transplantation Proceedings, October 2010, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  41. Results of renal re-transplant in Spain (1990-2002)

    Article • Clinical Kidney Journal, May 2010, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  42. Sirolimus monotherapy as maintenance immunosuppression: a multicenter experience

    Article • Transplant International, March 2010, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  43. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation

    Article • Nephrology Dialysis Transplantation, February 2010, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  44. Determinants of Resistive Index Shortly after Transplantation: Independent Relationship with Delayed Graft Function

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  45. Using RIFLE criteria to evaluate acute kidney injury in brain-deceased kidney donors

    Article • Nephrology Dialysis Transplantation, December 2009, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  46. Chronic allograft nephropathy – a clinical syndrome: early detection and the potential role of proliferation signal inhibitors

    Article • Clinical Transplantation, November 2009, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  47. Two-year follow-up of a prospective study of circulating regulatory T cells in renal transplant patients

    Article • Clinical Transplantation, September 2009, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  48. Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation

    Article • Transplant International, July 2009, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  49. Bone Metabolism According to Chronic Kidney Disease Stages in Patients Undergoing Kidney Transplantation: a 5-Year Database Analysis

    Article • Transplantation Proceedings, July 2009, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  50. Correlation of C0 and C2 Levels With Cyclosporine Side Effects in Kidney Transplantation

    Article • Transplantation Proceedings, July 2009, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  51. Use of Mycophenolate Sodium in Stable Renal Transplant Recipients in Spain: Preliminary Results of the MIDATA Study

    Article • Transplantation Proceedings, July 2009, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  52. Lung cavitation due toMycobacterium xenopiin a renal transplant recipient

    Article • Transplant Infectious Disease, June 2009, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  53. Chronic Renal Disease in Renal Transplant Patients: Management of Cardiovascular Risk Factors

    Article • Transplantation Proceedings, June 2009, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  54. Hemoglobin Level Variability in Renal Transplant Patients Treated With Erythropoiesis Stimulating Agents

    Article • Transplantation Proceedings, November 2008, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  55. Survival After Dialysis Initiation: A Comparison of Transplant Patients After Graft Loss Versus Nontransplant Patients

    Article • Transplantation Proceedings, November 2008, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  56. Association Between Serum Soluble CD30 and Serum Creatinine Before and After Renal Transplantation

    Article • Transplantation Proceedings, November 2008, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  57. Changes in the Expression of the Immunoglobulin-like Transcript 3 (ILT3) and ILT4 Receptors in Renal Allograft Recipients: Effect of Donor and Recipient Aging

    Article • Transplantation Proceedings, November 2008, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  58. TH17 Versus Treg Cells in Renal Transplant Candidates: Effect of a Previous Transplant

    Article • Transplantation Proceedings, November 2008, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  59. Antiphospholipid antibodies after renal transplantation and cardiovascular disease

    Article • Clinical Transplantation, May 2008, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  60. Prevention of murine lupus disease in (NZB×NZW)F1 mice by sirolimus treatment

    Article • Lupus, October 2007, SAGE Publications

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  61. Cytokine Polymorphisms and Risk of Infection After Kidney Transplantation

    Article • Transplantation Proceedings, September 2007, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  62. Early Sirolimus Use With Cyclosporine Elimination Does Not Induce Progressive Proteinuria

    Article • Transplantation Proceedings, September 2007, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  63. Evaluation of the Efficacy and Safety of the Conversion From a Calcineurin Inhibitor to an Everolimus-Based Therapy in Maintenance Renal Transplant Patients

    Article • Transplantation Proceedings, September 2007, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  64. Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry

    Article • Transplantation Proceedings, September 2007, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  65. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection

    Article • Clinical Transplantation, July 2007, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  66. New-Onset Diabetes after Kidney Transplantation: Risk Factors

    Article • Journal of the American Society of Nephrology, December 2006, American Society of Nephrology

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  67. Calcineurin Inhibitors Affect Circulating Regulatory T Cells in Stable Renal Transplant Recipients

    Article • Transplantation Proceedings, October 2006, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  68. Conversion to Everolimus in Kidney Transplant Recipients: A Safe and Simple Procedure

    Article • Transplantation Proceedings, October 2006, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  69. Relevance of Chronic Kidney Disease Classification (K/DOQI) in Renal Transplant Patients

    Article • Transplantation Proceedings, October 2006, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  70. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction

    Article • Nephrology Dialysis Transplantation, September 2006, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  71. Calcineurin Inhibitors, but not Rapamycin, Reduce Percentages of CD4+CD25+FOXP3+ Regulatory T Cells in Renal Transplant Recipients

    Article • Transplantation, August 2006, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  72. Non-immunologic intervention in chronic allograft nephropathy

    Article • Kidney International, December 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  73. Prevalence of Anemia in Renal Transplant Patients: Results From MOST, an Observational Trial

    Article • Transplantation Proceedings, November 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  74. Clinical Significance of Antiphospholipid Antibodies on Allograft and Patient Outcome After Kidney Transplantation

    Article • Transplantation Proceedings, November 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  75. Evolution of Proteinuria After Conversion From Calcineurin Inhibitors (CNI) to Sirolimus (SRL) in Renal Transplant Patients: A Multicenter Study

    Article • Transplantation Proceedings, November 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  76. Higher Initial Tacrolimus Blood Levels and Concentration-Dose Ratios in Kidney Transplant Recipients Who Develop Diabetes Mellitus

    Article • Transplantation Proceedings, November 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  77. Impact of HLA Antibodies on Transplant Glomerulopathy

    Article • Transplantation Proceedings, November 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  78. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation

    Article • Transplant International, October 2005, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  79. High Initial Blood Levels of Tacrolimus in Overweight Renal Transplant Recipients

    Article • Transplantation Proceedings, April 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  80. Change in Serum Creatinine Levels Between 6 and 12 Months and Kidney Graft Survival: Influence of Proteinuria

    Article • Transplantation Proceedings, April 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  81. Effect of Delayed Graft Function in Hypersensitized Kidney Transplant Recipients

    Article • Human Immunology, April 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  82. Markers of Fibrosis in Early Biopsies of Renal Transplants

    Article • Transplantation Proceedings, April 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  83. Similar Impact of Slow and Delayed Graft Function on Renal Allograft Outcome and Function

    Article • Transplantation Proceedings, April 2005, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  84. Association Between Pulse Pressure and Cardiovascular Disease in Renal Transplant Patients

    Article • American Journal of Transplantation, February 2005, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  85. Early Cyclosporine A Withdrawal in Kidney-Transplant Recipients Receiving Sirolimus Prevents Progression of Chronic Pathologic Allograft Lesions

    Article • Transplantation, November 2004, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  86. The macrophage infiltration index and matrix metalloproteinase-II expression as a predictor of chronic allograft rejection

    Article • Transplantation Proceedings, November 2004, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  87. Pleural effusion secondary to minoxidil in a peritoneal dialysis patient

    Article • Nephrology Dialysis Transplantation, September 2004, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  88. Creatinine Reduction Ratio on Post-Transplant Day Two as Criterion in Defining Delayed Graft Function

    Article • American Journal of Transplantation, July 2004, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  89. Early post-transplant renal allograft function between 1990 and 1998 in Spain

    Article • Nephrology Dialysis Transplantation, June 2004, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  90. Effect of early graft function on patient survival in renal transplantation

    Article • Transplantation Proceedings, August 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  91. Assessment of glomerular filtration rate in transplant recipients with severe renal insufficiency by Nankivell, Modification of Diet in Renal Disease (MDRD), and Cockroft-Gault equations

    Article • Transplantation Proceedings, August 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  92. De novo Hemolytic-Uremic Syndrome/Thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: role of sirolimus

    Article • Transplantation Proceedings, August 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  93. Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions

    Article • Transplantation Proceedings, August 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  94. Immunoprophylaxis with simulect (Basiliximab) in kidney transplantation: results from routine clinical practice at 18 kidney transplant units

    Article • Transplantation Proceedings, August 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  95. Pulse pressure is an independent risk factor of cardiovascular disease in renal transplant patients

    Article • Transplantation Proceedings, August 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  96. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study12

    Article • Transplantation, July 2003, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  97. Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival

    Article • Nephrology Dialysis Transplantation, May 2003, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  98. Valoración del filtrado glomerular mediante la fórmula peso/creatinina

    Article • Medicina Clínica, April 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  99. Quantitation of 24-hour urine protein excretion in kidney transplant patients by the use of protein to creatinine ratio

    Article • Transplantation Proceedings, March 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  100. Clinical relevance of posttransplantation HLA antibody monitoring by ELISA

    Article • Transplantation Proceedings, March 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  101. Posttransplant diabetes is a cardiovascular risk factor in renal transplant patients

    Article • Transplantation Proceedings, March 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  102. Valoración del filtrado glomerular mediante la fórmula peso/creatinina

    Article • Medicina Clínica, January 2003, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  103. Histopathological findings according to banff-97 classification system comparing tacrolimus versus cyclosporine

    Article • Transplantation Proceedings, August 2002, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  104. Return to dialysis after renal transplantation. Which would be the best way?

    Article • Kidney International, May 2002, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  105. Apolipoprotein C-III and E Polymorphisms and Cardiovascular Syndrome, Hyperlipidemia, and Insulin Resistance in Renal Transplantation

    Article • American Journal of Transplantation, April 2002, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  106. Immunohistochemical study of experimental acute cellular rejection

    Article • Transplantation Proceedings, March 2002, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  107. Association between the SstI polymorphism of the apolipoprotein C-III gene, glucose intolerance and cardiovascular risk in renal transplant recipients

    Article • Transplantation Proceedings, February 2002, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  108. Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant

    Article • Transplantation Proceedings, February 2002, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  109. Is there any correlation between pathologic changes for acute rejection in kidney transplantation (Banff 97) and graft function?

    Article • Transplantation Proceedings, February 2002, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  110. Persistent proteinuria as a useful parameter to distinguish between chronic renal rejection and cyclosporin nephrotoxicity

    Article • Transplantation Proceedings, February 2002, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  111. Article • International Urology and Nephrology, January 2002, Springer Science + Business Media

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  112. Article • International Urology and Nephrology, January 2002, Springer Science + Business Media

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  113. Article • International Urology and Nephrology, January 2002, Springer Science + Business Media

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  114. Clinical validation of the banff 97 classification for the diagnosis of rejection in kidney transplant

    Article • Transplantation Proceedings, November 2001, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  115. Effect of apolipoprotein E and C-III polymorphisms on lipid profile and cardiovascular risk in renal transplant recipients

    Article • Transplantation Proceedings, November 2001, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  116. Immunohistochemical study of a new experimental model of acute cellular xenograft rejection

    Article • Transplantation Proceedings, August 2000, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  117. Changes in serum concentrations of matrix metalloproteinases in kidney transplantation

    Article • Transplantation Proceedings, May 2000, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  118. Removal of xenoreactive antibodies by protein-A immunoadsorption: experience in 22 patients

    Article • Xenotransplantation, February 2000, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  119. Borderline changes in kidney transplantation: evolution of treated cases versus nontreated

    Article • Transplantation Proceedings, September 1999, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  120. Early cellular rejection of pig kidney perfused with manipulated human blood to avoid hyperacute rejection

    Article • Transplantation Proceedings, September 1999, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  121. Influence of donor age on Doppler spectrum in the early phase of renal transplantation

    Article • Transplantation Proceedings, September 1999, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  122. Model of a telematic network for communication between centers in a kidney transplant area

    Article • Transplantation Proceedings, September 1999, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  123. Serum levels of xenoantibodies in different groups of patients awaiting transplantation

    Article • Transplantation Proceedings, September 1999, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  124. Should aging recipients of kidney grafts receive less immunosuppression?

    Article • Transplantation Proceedings, September 1999, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  125. DIFFERENCES IN ANTI-CREG ANTIBODY FORMATION BETWEEN TRANSPLANTED AND NONTRANSPLANTED RENAL PATIENTS

    Article • Transplantation, April 1999, Wolters Kluwer Health

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  126. Acute renal failure with macrohaematuria - don't be fooled by larger hyperechogenic kidneys

    Article • Nephrology Dialysis Transplantation, July 1998, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  127. Recurrent graft pyelonephritis and pneumatouria resulting from a colovesical fistula secondary to silent diverticulitis

    Article • Nephrology Dialysis Transplantation, April 1998, Oxford University Press (OUP)

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  128. Effect of serum phosphate on parathyroid hormone secretion during hemodialysis

    Article • Kidney International, January 1998, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  129. Glioblastoma multiforme of donor origin after renal transplantation: Report of a case

    Article • Human Pathology, November 1993, Elsevier

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  130. Treatment of Guillain-Barré syndrome with protein-A immunoadsorption: Report of two cases

    Article • Annals of Neurology, May 1992, Wiley

    Dr JUAN CARLOS RUIZ SAN MILLÁN

  131. Interleukin-2 Deficit in Hemodialysis Patients. Role of Prostaglandins

    Article • Renal Failure, January 1992, Taylor & Francis

    Dr JUAN CARLOS RUIZ SAN MILLÁN